Antibodies to Toxoplasma gondii in Individuals with First-Episode Schizophrenia
Author(s) -
Robert H. Yolken,
Silke Bachmann,
I. Rouslanova,
Erik P. Lillehoj,
G. C. Ford,
E. Fuller Torrey,
Johannes Schröeder
Publication year - 2001
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1086/319221
Subject(s) - toxoplasma gondii , schizophrenia (object oriented programming) , antibody , immunology , medicine , immunoassay , toxoplasmosis , autoantibody , blot , immunoglobulin g , psychiatry , biology , gene , genetics
We employed enzyme immunoassay (EIA) and Western blotting techniques to measure the level of antibodies to Toxoplasma gondii proteins in serum samples from 38 individuals undergoing their first episode of schizophrenia and from a group of matched control subjects. We found that the individuals with first-episode schizophrenia had significantly increased levels of IgG, IgM, and IgA class antibodies to Toxoplasma proteins, as compared with the control subjects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom